MS: a main pathological characteristic of MS is gut microbiota dysbiosis [47,48], while the alteration in the gut microbiome reduces C-C chemokine receptor type 9+ (CCR9+) cells, which express transcription factor c-Maf in high levels, leading to an increased expression of retinoic acid-related orphan receptor gamma t (RORγt) and proinflammatory cytokine IL-17/interferon-γ (IFNγ) in secondary progression MS (SPMS) patients [46] (Figure 2). The gene discussed is IFNG; the disease is myeloid sarcoma.